Proposal to list medical devices supplied by Jackson Allison Medical & Surgical Limited

Hospital devices Consultation Closes 27 Feb

What we’re proposing

Pharmac is seeking feedback on a proposal to list a range of medical devices supplied by Jackson Allison Medical & Surgical Limited (“Jackson Allison”) in Part III of Section H of the Pharmaceutical Schedule from 1 April 2025 in the following categories:

medical and surgical instruments and power tools

sterilisation and decontamination equipment and associated consumables

Consultation closes at 4 pm on 27 February 2025, and feedback can be emailed to alishba.ali@pharmac.govt.nz

What would the effect be?

From 1 April 2025, Jackson Allison’s range of medical devices in the medical and surgical instruments and power tools and the sterilisation and decontamination equipment and associated consumables categories would be listed under a national agreement for all Health New Zealand | Te Whatu Ora (“Health NZ”) hospitals to purchase under, subject to consultation and approval by Pharmac’s Board or delegate.

The agreement would not be for sole supply, with Health NZ continuing to be able to purchase other suppliers’ brands of medical and surgical instruments and power tools and sterilisation and decontamination equipment and associated consumables.

The agreement would supersede any existing Health NZ contracts with Jackson Allison for the medical devices listed in the agreement. Any device listed in the Pharmac agreement and purchased by a Health NZ hospital would be at the price, terms and conditions stated in the agreement, effective from the date of listing on the Pharmaceutical Schedule.

Who we think will be interested

  • Health NZ hospital staff including:
    • Clinical engineers and maintenance services
    • ICU, emergency, and critical care staff
    • Neurologists and Neurosurgeons
    • Nurses
    • Ophthalmologists
    • Perioperative staff
    • Procurement and supply chain
    • Sterile services personnel
    • Surgeons
    • Surgical and general ward staff
  • Suppliers and wholesalers
  • Equipment validation service providers
  • Professional bodies
    • NZNO
    • Sterile Services Associated NZ

About these products

Medical and surgical instruments and power tool products are used in a vast range of medical and surgical specialities and procedures. Some are more generally used within clinical practice and others have highly specific applications. Some require power sources or other equipment to perform their function.

Sterilisation and decontamination equipment and associated consumables are medical devices used in surgical and non-surgical procedures primarily to achieve the disinfection and sterilisation of equipment and reusable medical devices. The products vary relating to their purpose, function, application, and clinical indication.

Why we’re proposing this

In 2021, Pharmac issued a Request for Proposals (“RFP”) for the supply of surgical implants, medical and surgical instruments and power tools, and associated products. The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.

In 2021, Pharmac issued a Request for Proposals (“RFP”) for the supply of supply of sterilisation and decontamination equipment and consumables. The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.

Pharmac has been working with suppliers who responded to these RFPs and were successful in being progressed to contract negotiation to seek provisional agreements. This is the latest proposal to arise from these processes.

Details about our proposal

The proposal would result in 153 medical devices being listed in the Pharmaceutical Schedule covering the following brands:

Category

Number of devices

Brands

Medical and surgical instruments and power tools

148

  • DeRoyal Industries
  • Dima Surgical Instruments
  • Galaxy II
  • Ivalon
  • REDA
  • VBM

Sterilisation and decontamination equipment and associated consumables

5

  • Parasure

Further information, including pricing and contractual details, has been provided to Health NZ procurement personnel. Clinicians interested in further detail on what this proposal means for their hospital should engage with the Health NZ procurement team.

To provide feedback

Send us an email: alishba.ali@pharmac.govt.nz by 4 pm on 27 February 2025.

All feedback received before the closing date will be considered by Pharmac’s Board (or its delegate) prior to making a decision on this proposal.

Your feedback may be shared

When you give feedback on a consultation, your feedback becomes official information that Pharmac holds. Pharmac has legal responsibilities for how we manage this official information, under laws such as the Official Information Act and Privacy Act.

Pharmac may receive a request from people for official information, which could include your feedback. Legally, Pharmac must consider whether your feedback should be released.

We will consider your views when assessing whether the feedback has to be released. Tell us if there is anything about your feedback that you would prefer wasn’t released.

If your feedback is proposed for release, then Pharmac will contact you, unless there is a legal reason that we can't.

Note that Pharmac collects and holds your information in line with our Privacy Statement.